South San Francisco, CA, United States of America

Chong Han

This inventor holds 14 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Genentech, Inc., Array Biopharma Inc., F. Hoffmann-La Roche Ag. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chong Han. Retrieved from https://idiyas.com/inventor/chong-han

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 92.9

 

 

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 34(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2015 - 2020)
  • Foster City, CA (US) (2018 - 2024)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Polymorphs
Quinazoline
Piperazine
Cyclopentyl
Lactam
Hydroxylated
Intermediates
Synthesis
14 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Chong Han

Introduction

Chong Han is a prominent inventor based in South San Francisco, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of 14 patents to his name, his work has had a substantial impact on medical research and drug development.

Latest Patents

Chong Han's latest patents include innovative formulations such as polymorphs and solid forms of (S)-2-2((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide. He has also developed methods for producing crystalline polymorph forms of (S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide (GDC-0077). Additionally, he has provided processes for synthesizing quinazoline compounds that are useful in cancer treatment.

Career Highlights

Chong Han has worked with notable companies in the pharmaceutical industry, including Genentech, Inc. and Array Biopharma Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.

Collaborations

Chong has collaborated with esteemed colleagues such as Francis Gosselin and Scott J Savage. These partnerships have fostered innovation and have been instrumental in advancing their shared goals in pharmaceutical research.

Conclusion

Chong Han's contributions to the field of pharmaceuticals through his patents and collaborations highlight his dedication to improving cancer treatment. His innovative work continues to influence the industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…